Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 February 2024 | Story Leonie Bolleurs | Photo SUPPLIED
Dr Lindie von Maltitz
Dr Lindie von Maltitz spoke at DESTEA’s Free State Investment Conference (27 February), which was hosted on the UFS Bloemfontein Campus. In her presentation, she highlighted, among other points, the advantages of the UFS as a strategic partner in the agricultural sector.

Dr Lindie von Maltitz, a Lecturer in the Department of Agricultural Economics at the University of the Free State (UFS), contributed to the programme of the Free State Investment Conference (27 February), which was presented by the Department of Economic, Small Business Development, Tourism, and Environmental Affairs (DESTEA).

The primary objective of the conference, held in the Centenary Complex on the UFS Bloemfontein Campus, was to promote the province as an investment destination of choice and to showcase strategic investment projects across different municipalities. Additionally, the conference sought to connect local businesses with local and international investors and opportunities.

Representatives from financial institutions, academic institutions, national and provincial government departments, chambers of commerce, corporates, investors, and embassies attended the conference, which was opened by Councillor Gregory Nthatisi, the Executive Mayor of the Mangaung Metropolitan Municipality. The honourable Mxolisi Dukwana, the Premier of the Free State, delivered the keynote address.

The sectors covered by the presentations at this conference included mining and gas extraction, transport and logistics, energy, infrastructure, tourism, and the agriculture and agro-processing sector. Dr Von Maltitz’s presentation, ‘Required investment to improve the performance of the agricultural sector in the Free State’, focused on the latter sector.

Representing the UFS in the session ‘Driving Inclusive Growth and Food Security: Agriculture’ – Dr Von Maltitz first focused on what agriculture in the Free State entails, and how it relates to the rest of the country. She then provided a brief overview of the role and importance of agriculture in the South African and Free State economy, adding to that the advantages that investment in the agricultural sector in the Free State will bring.

Numerous possibilities for investment in the sector

According to Dr Von Maltitz, the agricultural sector in the Free State is of vital importance to its economy. “Our income from agriculture and its related industries is the second largest in the country, after the Western Cape. There are numerous possibilities for investment in the sector, not limited to production, but expanded to the entire agricultural value chain. Connecting with the right strategic partners can ensure the success of investment projects. The UFS can contribute as a strategic partner, bringing knowledge, expertise, research, and local and global networking to the table,” she stated.

The importance of investing in the agricultural sector, according to Dr Von Maltitz, is linked to two of South Africa’s biggest challenges: unemployment and poverty. “Investing in agriculture addresses both of these issues. Jobs are created for both unskilled and skilled labour while producing and processing food. The higher agricultural investment is on the agenda, the better for economic growth in our province and country,” said Dr Von Maltitz.

"With food security for a global population that has expanded from 2,5 billion in 1950 to 7,9 billion in 2021, agriculture and its related industries are the sector that will remain important until time immemorial,” remarked Dr Von Maltitz.

She is of the opinion that the Free State presents many opportunities for this sector. Dr Von Maltitz believes there are very few agricultural products that cannot be produced in the Free State. “For example, fruit produced in our province is market-ready before that of the Western Cape. This allows us to access local and international markets early, when prices are higher due to a supply shortage. Because we have cold temperatures in winter, our area has fewer livestock diseases than those found in other parts of the country,” she added.

“Assured by a supportive policy environment, functional infrastructure, and expert knowledge base, investors can be encouraged to invest in the agricultural sector in the Free State,” said Dr Von Maltitz.

In the Free State, however, the development of the agricultural sector is facing several challenges. In her view, failing infrastructure and load shedding are the biggest problems. “Our roads are among the worst in the country, making timely access to markets more difficult. Load shedding has an enormous impact on any processing facility. Climate change is something we need to incorporate into our planning process, continuously developing new risk management strategies for the sector,” she elaborated.

Advantages of the UFS as a strategic partner

She stated that the Free State is an agricultural hub open to many more possibilities. “Speaking as a representative of the UFS, I want to highlight the advantages for investors of the UFS as a strategic partner. Our Faculty of Natural and Agricultural Sciences is one of the best in the country and offers knowledge, skills, and expertise in every field related to agriculture, including soil scientists, animal scientists, climate scientists, crop scientists, wildlife and grassland scientists, plant breeders and pathologists, agronomists, agrometeorologists, and agricultural economists. The value we offer can be attractive to investors who will be reassured by our competence, as supported in the university’s Vision130, which defines our values, namely excellence, innovation and impact, accountability, care, social justice, and sustainability,” Dr Von Maltitz said.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept